CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.

di Kirby P Gardner, Susan Tsai, Mohammed Aldakkak, Stephen Gironda, Daniel L Adams
Pubblicazione 2022-01-01

Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy

di Chad A. Barnes, Mohammed Aldakkak, Callisia N. Clarke, Kathleen K. Christians, Daniel Bucklan, Michael Holt, Parag Tolat, Paul S. Ritch, Ben George, William A. Hall, Beth A. Erickson, Douglas B. Evans, Susan Tsai
Pubblicazione 2020-04-01